Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)
This study has been completed.
Study NCT00097929 Information provided by Merck Sharp & Dohme Corp.
First Received on December 1, 2004. Last Updated on August 25, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Lymphoma, Large B-Cell, Diffuse
More general conditions related to this trial
Immune System Diseases
Neoplasms by Histologic Type
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Histone Deacetylase Inhibitors
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers